BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

240 related articles for article (PubMed ID: 18031829)

  • 21. CLTA-4 blockade in vivo promotes the generation of short-lived effector CD8 T cells and a more persistent central memory CD4 T cell response.
    Hokey DA; Yan J; Hirao LA; Dai A; Boyer JD; Jure-Kunkel MN; Weiner DB
    J Med Primatol; 2008 Dec; 37 Suppl 2():62-8. PubMed ID: 19187432
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Differential expression of CTLA-4 among T cell subsets.
    Jago CB; Yates J; Câmara NO; Lechler RI; Lombardi G
    Clin Exp Immunol; 2004 Jun; 136(3):463-71. PubMed ID: 15147348
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Schistosoma mansoni PIII antigen modulates in vitro granuloma formation by regulating CD28, CTLA-4, and CD86 expression in humans.
    Zouain CS; Falcão PL; Goes TS; Leite MF; Goes AM
    Immunol Lett; 2004 Feb; 91(2-3):113-8. PubMed ID: 15019278
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Suppressive properties of human CD4+CD25+ regulatory T cells are dependent on CTLA-4 expression.
    Birebent B; Lorho R; Lechartier H; de Guibert S; Alizadeh M; Vu N; Beauplet A; Robillard N; Semana G
    Eur J Immunol; 2004 Dec; 34(12):3485-96. PubMed ID: 15484187
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Phosphodiesterase 7A1 is expressed in human CD4+ naïve T cells at higher levels than in CD4+ memory cells and is not required during their CD3/CD28-dependent activation.
    Nueda A; García-Roger N; Domenech T; Godessart N; Cárdenas A; Santamaría-Babi LF; Beleta J
    Cell Immunol; 2006 Jul; 242(1):31-8. PubMed ID: 17034773
    [TBL] [Abstract][Full Text] [Related]  

  • 26. B7-H1 on hepatocytes facilitates priming of specific CD8 T cells but limits the specific recall of primed responses.
    Wahl C; Bochtler P; Chen L; Schirmbeck R; Reimann J
    Gastroenterology; 2008 Sep; 135(3):980-8. PubMed ID: 18621049
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The mucosal adjuvanticity of cholera toxin involves enhancement of costimulatory activity by selective up-regulation of B7.2 expression.
    Cong Y; Weaver CT; Elson CO
    J Immunol; 1997 Dec; 159(11):5301-8. PubMed ID: 9548469
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Generation of highly suppressive adaptive CD8(+)CD25(+)FOXP3(+) regulatory T cells by continuous antigen stimulation.
    Mahic M; Henjum K; Yaqub S; Bjørnbeth BA; Torgersen KM; Taskén K; Aandahl EM
    Eur J Immunol; 2008 Mar; 38(3):640-6. PubMed ID: 18266270
    [TBL] [Abstract][Full Text] [Related]  

  • 29. CTLA-4 regulates the murine immune response to Trypanosoma cruzi infection.
    Graefe SE; Jacobs T; Wächter U; Bröker BM; Fleischer B
    Parasite Immunol; 2004 Jan; 26(1):19-28. PubMed ID: 15198642
    [TBL] [Abstract][Full Text] [Related]  

  • 30. CD28 costimulation overcomes transforming growth factor-beta-mediated repression of proliferation of redirected human CD4+ and CD8+ T cells in an antitumor cell attack.
    Koehler H; Kofler D; Hombach A; Abken H
    Cancer Res; 2007 Mar; 67(5):2265-73. PubMed ID: 17332357
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Unique phenotype of human tonsillar and in vitro-induced FOXP3+CD8+ T cells.
    Siegmund K; Rückert B; Ouaked N; Bürgler S; Speiser A; Akdis CA; Schmidt-Weber CB
    J Immunol; 2009 Feb; 182(4):2124-30. PubMed ID: 19201865
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Requirements for the functional expression of OX40 ligand on human activated CD4+ and CD8+ T cells.
    Kondo K; Okuma K; Tanaka R; Zhang LF; Kodama A; Takahashi Y; Yamamoto N; Ansari AA; Tanaka Y
    Hum Immunol; 2007 Jul; 68(7):563-71. PubMed ID: 17584577
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A mutant B7-1/Ig fusion protein that selectively binds to CTLA-4 ameliorates anti-tumor DNA vaccination and counters regulatory T cell activity.
    Chakrabarti R; Zhou ZF; Chang Y; Prud'homme GJ
    Vaccine; 2005 Aug; 23(37):4553-64. PubMed ID: 15919138
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Human CD4+ T lymphocytes with increased intracellular cAMP levels exert regulatory functions by releasing extracellular cAMP.
    Vendetti S; Patrizio M; Riccomi A; De Magistris MT
    J Leukoc Biol; 2006 Oct; 80(4):880-8. PubMed ID: 16888088
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Recombinant human erythropoietin treatment of chronic renal failure patients normalizes altered phenotype and proliferation of CD4-positive T lymphocytes.
    Lisowska KA; Debska-Slizien A; Radzka M; Witkowski JM; Rutkowski B; Bryl E
    Artif Organs; 2010 Mar; 34(3):E77-84. PubMed ID: 20447038
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Involvement of CTLA-4 in T-cell anergy induced by staphylococcal enterotoxin A in vitro.
    Xu GL; Zhu XH; Guo B; Wu YZ
    Mol Immunol; 2004 May; 41(1):1-8. PubMed ID: 15140570
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Evaluation of expression patterns of feline CD28 and CTLA-4 in feline immunodeficiency virus (FIV)-infected and FIV antigen-induced PBMC.
    Choi IS; Yoo HS; Collisson EW
    J Vet Sci; 2000 Dec; 1(2):97-103. PubMed ID: 14614304
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Novel human CD4+ T lymphocyte subpopulations defined by CD300a/c molecule expression.
    Clark GJ; Rao M; Ju X; Hart DN
    J Leukoc Biol; 2007 Nov; 82(5):1126-35. PubMed ID: 17702825
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Costimulation of the CD3 pathway by CD28 ligation in human intestinal lymphocytes.
    Ebert EC; Roberts AI
    Cell Immunol; 1996 Aug; 171(2):211-6. PubMed ID: 8806789
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Costimulatory molecules and cytokine production by T lymphocytes in common variable immunodeficiency disease.
    Pons J; Ferrer JM; Martínez-Pomar N; Iglesias-Alzueta J; Matamoros N
    Scand J Immunol; 2006 May; 63(5):383-9. PubMed ID: 16640663
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.